Could a laser ease painful sex for millions of women?
NCT ID NCT05597358
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether high-intensity laser therapy (HILT) can reduce pain during intercourse for women with provoked vestibulodynia, a condition causing severe pain at the vaginal opening. About 145 women with moderate to severe pain will receive either real or sham laser treatments twice a week for six weeks. Researchers will measure changes in pain, sexual function, and quality of life up to six months after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High Intensity Laser Therapy (Nd:Yag 1064 nm)
What this could lead to
If effective, this could offer a non-drug, non-surgical option to reduce pain during intercourse for women with provoked vestibulodynia.
What could go wrong
This is a relatively small trial (145 participants) testing a device, and the sham group may also show improvement due to placebo effects. Long-term benefits are not yet known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVODYNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire de Québec - Université Laval
Québec, Quebec, G1V 4G2, Canada
-
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, J1H 5N4, Canada
-
Exogenia
Sherbrooke, Quebec, J1L 1C6, Canada
-
Kinatex l'Ormière
Québec, Quebec, G2B 3K3, Canada